New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 28, 2013
07:16 EDTECYT, SGENEndocyte added to Top Picks list; Seattle Genetics removed at Credit Suisse
Credit Suisse added Endocyte to the Top Picks list based on vintafolide regulatory and clinical events over the next 12 months, a strong cash position, and asset ownership, among other reasons.
News For ECYT;SGEN From The Last 14 Days
Check below for free stories on ECYT;SGEN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 9, 2014
10:02 EDTSGENOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
05:59 EDTSGENSeattle Genetics upgraded to Buy from Neutral at UBS
Subscribe for More Information
July 8, 2014
05:30 EDTECYTEndocyte assumed with a Buy at Brean Capital
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use